Search Videos and More

Showing 1 - 12 of 334 results

Previous| 1 | 2 | 3 ...28 |Next


Antibody-Drug Conjugates: A Cancer Therapy Revolution News

Antibody-Drug Conjugates: A Cancer Therapy Revolution

Dana-Farber researchers explore how a novel therapy may benefit patients
Kate Dibble, PhD Discusses Ovarian Function Suppression Video

Kate Dibble, PhD Discusses Ovarian Function Suppression

Dana-Farber's Heather Parsons, MD, MPH, discusses a new study showing liquid biopsy could reliably determine whether a patient's breast cancer is HER2-positive or --negative.
Paolo Tarantino, MD Discusses RELIEVE Study Video

Paolo Tarantino, MD Discusses RELIEVE Study

Dana-Farber's Paolo Tarantino, MD, presented results from the RELIEVE study showing patients with metastatic breast cancer receiving trastuzumab deruxtecan fared best if they had HER2+ disease or stable HER2-low disease.
Heather Parsons, MD, MPH Discusses Liquid Biopsy Video

Heather Parsons, MD, MPH Discusses Liquid Biopsy

Dana-Farber's Heather Parsons, MD, MPH, discusses a new study showing liquid biopsy could reliably determine whether a patient's breast cancer is HER2-positive or --negative.
Dana-Farber Research Publication 01.01.2023 News

Dana-Farber Research Publication 01.01.2023

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 12.15.2022 News

Dana-Farber Research Publication 12.15.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 12.1.2022 News

Dana-Farber Research Publication 12.1.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
American Society of Hematology (ASH) 2023 Symposium

American Society of Hematology (ASH) 2023

Review presentations and information shared by Dana-Farber physician-scientists at the 66th American Society of Hematology Annual Meeting & Exposition in San Diego.
San Antonio Breast Cancer Symposium (SABCS) 2023 Symposium

San Antonio Breast Cancer Symposium (SABCS) 2023

2023 Updates in Neuro-Oncology News

2023 Updates in Neuro-Oncology

Please join us on Zoom for a free symposium on the latest advances in neuro-oncology. Through lecture and discussion, Harvard Medical School faculty will consider how to apply recent clinical research advances to improve the care and outcomes of patients with brain tumors.
Dana-Farber Research Publication 11.15.2022 News

Dana-Farber Research Publication 11.15.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
ESMO Congress 2023 Research Highlights Symposium

ESMO Congress 2023 Research Highlights

Lung, kidney, and neuroendocrine tumor cancer studies led by Dana-Farber presented at ESMO Congress 2023.

Showing 1 - 12 of 334 results

Previous| 1 | 2 | 3 ...28 |Next